# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001798749-24-000003
Filing Date
2024-01-08
Accepted
2024-01-08 07:59:17
Documents
46
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | tmb-20240108x8k.htm iXBRL | 8-K | 45431
2 | EX-99.1 | tmb-20240108xex99d1.htm | EX-99.1 | 49869
3 | GRAPHIC | tmb-20240108xex99d1g001.jpg | GRAPHIC | 73625
4 | GRAPHIC | tmb-20240108xex99d1g002.jpg | GRAPHIC | 246881
5 | GRAPHIC | tmb-20240108xex99d1g003.jpg | GRAPHIC | 131998
6 | GRAPHIC | tmb-20240108xex99d1g004.jpg | GRAPHIC | 101562
7 | GRAPHIC | tmb-20240108xex99d1g005.jpg | GRAPHIC | 96497
8 | GRAPHIC | tmb-20240108xex99d1g006.jpg | GRAPHIC | 61973
9 | GRAPHIC | tmb-20240108xex99d1g007.jpg | GRAPHIC | 75334
10 | GRAPHIC | tmb-20240108xex99d1g008.jpg | GRAPHIC | 54263
11 | GRAPHIC | tmb-20240108xex99d1g009.jpg | GRAPHIC | 88244
12 | GRAPHIC | tmb-20240108xex99d1g010.jpg | GRAPHIC | 98391
13 | GRAPHIC | tmb-20240108xex99d1g011.jpg | GRAPHIC | 110213
14 | GRAPHIC | tmb-20240108xex99d1g012.jpg | GRAPHIC | 42640
15 | GRAPHIC | tmb-20240108xex99d1g013.jpg | GRAPHIC | 69987
16 | GRAPHIC | tmb-20240108xex99d1g014.jpg | GRAPHIC | 129640
17 | GRAPHIC | tmb-20240108xex99d1g015.jpg | GRAPHIC | 68295
18 | GRAPHIC | tmb-20240108xex99d1g016.jpg | GRAPHIC | 71728
19 | GRAPHIC | tmb-20240108xex99d1g017.jpg | GRAPHIC | 86783
20 | GRAPHIC | tmb-20240108xex99d1g018.jpg | GRAPHIC | 96935
21 | GRAPHIC | tmb-20240108xex99d1g019.jpg | GRAPHIC | 83654
22 | GRAPHIC | tmb-20240108xex99d1g020.jpg | GRAPHIC | 66401
23 | GRAPHIC | tmb-20240108xex99d1g021.jpg | GRAPHIC | 88546
24 | GRAPHIC | tmb-20240108xex99d1g022.jpg | GRAPHIC | 98105
25 | GRAPHIC | tmb-20240108xex99d1g023.jpg | GRAPHIC | 116891
26 | GRAPHIC | tmb-20240108xex99d1g024.jpg | GRAPHIC | 104719
27 | GRAPHIC | tmb-20240108xex99d1g025.jpg | GRAPHIC | 89365
28 | GRAPHIC | tmb-20240108xex99d1g026.jpg | GRAPHIC | 85691
29 | GRAPHIC | tmb-20240108xex99d1g027.jpg | GRAPHIC | 66151
30 | GRAPHIC | tmb-20240108xex99d1g028.jpg | GRAPHIC | 71663
31 | GRAPHIC | tmb-20240108xex99d1g029.jpg | GRAPHIC | 74125
32 | GRAPHIC | tmb-20240108xex99d1g030.jpg | GRAPHIC | 69950
33 | GRAPHIC | tmb-20240108xex99d1g031.jpg | GRAPHIC | 71704
34 | GRAPHIC | tmb-20240108xex99d1g032.jpg | GRAPHIC | 101540
35 | GRAPHIC | tmb-20240108xex99d1g033.jpg | GRAPHIC | 37940
| Complete submission text file | 0001798749-24-000003.txt |  | 4277204

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
36 | EX-101.SCH | tmb-20240108.xsd | EX-101.SCH | 3124
37 | EX-101.LAB | tmb-20240108_lab.xml | EX-101.LAB | 16578
38 | EX-101.PRE | tmb-20240108_pre.xml | EX-101.PRE | 10780
40 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20240108x8k_htm.xml | XML | 4990

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 24518375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)